- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04897932
Evaluation Trial of Handheld Urinal for Adult Use
An Evaluation of the Usability and Efficacy of a Prototype Handheld Urinal for Adults Who Suffer From Nocturia, Urge, Frequency, and/or Functional Incontinence
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Keith A Binding, MBA
- Phone Number: +441295 408029
- Email: keith@bindingsciences.com
Study Contact Backup
- Name: Melissa Odling, MEng
- Phone Number: +441295 408029
- Email: melissa@bindingsciences.com
Study Locations
-
-
Oxfordshire
-
Cropredy, Oxfordshire, United Kingdom, OX17 1PX
- Binding Sciences Limited
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Suffers from nocturia urge, frequency, or funnctional incontinence
Exclusion Criteria:
- Suffers only from stress UI
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Adult nocturia
Use of device over 28 days
|
Ad hoc use of handheld urinal
|
|
Active Comparator: Adult urge urinary incontinence
Use of device over 28 days
|
Ad hoc use of handheld urinal
|
|
Active Comparator: Adult frequency urinary incontinence
Use of device over 28 days
|
Ad hoc use of handheld urinal
|
|
Active Comparator: Adult functional incontinence
Use of device over 28 days
|
Ad hoc use of handheld urinal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in fluid intake
Time Frame: 28 days
|
Quantitative analysis of levels of daily fluid intake i) when using the device and ii) not using the device.
|
28 days
|
|
Change in incidence of falls associated with urinary toileting
Time Frame: 28 days (3 months reported number of falls based on participant's recollection of incidence during that period)
|
Quantitative analysis of the number of falls incurred going to and from toilet while using the device over the 28 day study period compared to the number of falls recalled by participants going to and from the toilet during the 3 months prior to the study when not using the device. Tool: user diary and questionairre |
28 days (3 months reported number of falls based on participant's recollection of incidence during that period)
|
|
Change in level of user independence
Time Frame: 28 days
|
Quantitative assessment of number of carer interventions required to assist users with urinary toileting when using and not using the device. Tool: user diary and questionairre |
28 days
|
|
Levels of user confidence
Time Frame: 28 days
|
Qualitative self-assessments, on a three-point scale of "Not at all confident", "Reasonably confident" and "Very confident", by users of their confidence in their ability to manage urinary incontinence when using the device in a range of different orientations. Tool: questionairre |
28 days
|
|
Convenience in use
Time Frame: 28 days
|
Qualitative self-assessment by users of the convenience in use of the device relative to other continence aids used on a three-point scale: "More convenient", "Neither more nor less convenient", and "Less convenient". Tool: questionairre |
28 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Piers Clifford, MD, Buckinghamshire Healthcare NHS Trust
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BSL BHT IRAS 291714
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Ludwig-Maximilians - University of MunichUnknownIncontinence, Overactive Bladder, Stress Urinary IncontinenceGermany
-
San Diego Sexual MedicineRecruitingStress Urinary Incontinence | Urge IncontinenceUnited States
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedStress Urinary Incontinence | Urge Urinary IncontinenceDenmark
-
ScitonCompletedUrinary Incontinence | Stress Urinary Incontinence | Urge IncontinenceUnited States
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
University of ZurichCompletedStress Urinary Incontinence | Urge Urinary Incontinence
-
GT Urological, LLCCompletedMale Stress Urinary IncontinenceAustralia, Czechia, New Zealand
-
Zekai Tahir Burak Women's Health Research and Education...CompletedFemale Urinary Stress IncontinenceTurkey
Clinical Trials on RS - WP06
-
GrayMatters Health Ltd.Completed
-
RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret...CompletedSolid TumorsTurkey (Türkiye)
-
Mathematica Policy Research, Inc.Department of Health and Human ServicesWithdrawnAttitude | KnowledgeUnited States
-
Chinese University of Hong KongRecruitingIVF | Reproductive Issues | SubfertilityHong Kong
-
Uppsala UniversitySwedish University of Agricultural SciencesCompletedRespiratory Tract Infections | Respiratory Syncytial Virus InfectionsSweden
-
Guangzhou Shijing Medical SoftwareZhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknownIntermittent ExotropiaChina
-
Metagenics, Inc.National University of Natural Medicine; Personalized Lifestyle Medicine CenterCompleted
-
VA Office of Research and DevelopmentCompletedAutologous Hematopoietic Stem Cell TransplantUnited States
-
Bio-Medical Research, Ltd.Completed